-
Zelensky looks to close out Ukraine peace deal at Trump meet
-
MCG curator in 'state of shock' after Ashes Test carnage
-
Texans edge Chargers to reach NFL playoffs
-
Osimhen and Mane score as Nigeria win to qualify, Senegal draw
-
Osimhen stars as Nigeria survive Tunisia rally to reach second round
-
How Myanmar's junta-run vote works, and why it might not
-
Watkins wants to sicken Arsenal-supporting family
-
Arsenal hold off surging Man City, Villa as Wirtz ends drought
-
Late penalty miss denies Uganda AFCON win against Tanzania
-
Watkins stretches Villa's winning streak at Chelsea
-
Zelensky stops in Canada en route to US as Russia pummels Ukraine
-
Arteta salutes injury-hit Arsenal's survival spirit
-
Wirtz scores first Liverpool goal as Anfield remembers Jota
-
Mane rescues AFCON draw for Senegal against DR Congo
-
Arsenal hold off surging Man City, Wirtz breaks Liverpool duck
-
Arsenal ignore injury woes to retain top spot with win over Brighton
-
Sealed with a kiss: Guardiola revels in Cherki starring role
-
UK launches paid military gap-year scheme amid recruitment struggles
-
Jota's children join tributes as Liverpool, Wolves pay respects
-
'Tired' Inoue beats Picasso by unanimous decision to end gruelling year
-
Thailand and Cambodia declare truce after weeks of clashes
-
Netanyahu to meet Trump in US on Monday
-
US strikes targeted IS militants, Lakurawa jihadists, Nigeria says
-
Cherki stars in Man City win at Forest
-
Schwarz records maiden super-G success, Odermatt fourth
-
Russia pummels Kyiv ahead of Zelensky's US visit
-
Smith laments lack of runs after first Ashes home Test loss for 15 years
-
Russian barrage on Kyiv kills one, leaves hundreds of thousands without power
-
Stokes, Smith agree two-day Tests not a good look after MCG carnage
-
Stokes hails under-fire England's courage in 'really special' Test win
-
What they said as England win 4th Ashes Test - reaction
-
Hong Kongers bid farewell to 'king of umbrellas'
-
England snap 15-year losing streak to win chaotic 4th Ashes Test
-
Thailand and Cambodia agree to 'immediate' ceasefire
-
Closing 10-0 run lifts Bulls over 76ers while Pistons fall
-
England 77-2 at tea, need 98 more to win chaotic 4th Ashes Test
-
Somalia, African nations denounce Israeli recognition of Somaliland
-
England need 175 to win chaotic 4th Ashes Test
-
Cricket Australia boss says short Tests 'bad for business' after MCG carnage
-
Russia lashes out at Zelensky ahead of new Trump talks on Ukraine plan
-
Six Australia wickets fall as England fight back in 4th Ashes Test
-
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
-
Dental Implant Financing and Insurance Options in Georgetown, TX
-
Man Utd made to 'suffer' for Newcastle win, says Amorim
-
Morocco made to wait for Cup of Nations knockout place after Egypt advance
-
Key NFL week has playoff spots, byes and seeds at stake
-
Morocco forced to wait for AFCON knockout place after Mali draw
-
Dorgu delivers winner for depleted Man Utd against Newcastle
-
US stocks edge lower from records as precious metals surge
-
Somalia denounces Israeli recognition of Somaliland
French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
X.Karnes--AMWN